Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer.

Drug scheduling alterations can improve the therapeutic index of both 5-fluorouracil and anthracyclines. We investigated a regimen of weekly doxorubicin and continuous infusional 5-fluorouracil (AcF) in loco-regionally recurrent and metastatic breast cancer. The aims of this phase II study were to u...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabra, H., Cameron, D. A., Lee, L. E., Mackay, J., Leonard, R. C.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074814/
https://www.ncbi.nlm.nih.gov/pubmed/8980405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074814/
https://www.ncbi.nlm.nih.gov/pubmed/8980405

Ejemplares similares